Patent ID: 8980338
Filing Date: 2015-03-17
Classification: A61K,A61P

Abstract:
1. A method of treating a patient suffering from a psychological or psychiatric disorder selected from one or more of a group consisting of anxiety, stress, tension or sleep disturbance, comprising administering to the patient in need thereof an effective amount of a composition comprising as an active ingredient an extract of a plant or plants from family Mesembryanthemaceae, genus Sceletium , as a dual serotonin uptake inhibitor and PDE4 inhibitor, the extract including alkaloids mesembrenol and mesembrenone and having a total Mesembryanthemaceae alkaloid content, wherein combined content of mesembrenol and mesembrenone in the extract is greater than 80% (w/w) of the total Mesembryanthemaceae alkaloid content and mesembrine content in the extract is less than 15% (w/w) of the total Mesembryanthemaceae alkaloid content, wherein the composition is in unit dosage form, and wherein a unit dose of the composition contains 1 microgram to 1000 micrograms of the total Mesembryanthemaceae alkaloid content.